The European Federation for Medicinal Chemistry (EFMC) is an independent association representing medicinal chemistry societies in Europe. Its objective is to advance the science of medicinal chemistry by promoting cooperation and networking, by providing training and mentoring, by rewarding scientific excellence, and by facilitating communication and influencing stakeholders.

Meetings  February 2019 Next

Advisory Board

Koen AUGUSTYNS (University of Antwerp, Belgium)

AB Members

Maria Laura BOLOGNESI (University of Bologna, Italy)
Karin BRINER (Novartis, USA)
François DIEDERICH (ETH Zürich, Switzerland)
Anette GRAVEN SAMS (Lundbeck, Denmark)
Herbert WALDMANN (Max Planck Institute of Molecular Physiology, Germany)
Tony WOOD (GlaxoSmithKline, United Kingdom)

The Advisory Board is an EFMC consulting body for the executive committee assisting in assessing the Federation's strategic goals. The tasks of the AB consists of:

• advising on EFMC policy related matters internally and externally
• proposing novel scientific or political initiatives to the Executive Committee
• proposing strategies how to increase awareness of Medicinal Chemistry and support of the community in Europe
• proposing strategies how to affect and interact with stakeholders in Europe
The AB is composed of eminent scientists in the life sciences and medicinal chemistry and is chaired by the past president.

28 29 30 31 01 02 03
04 05 06 07 08 09 10
11 12 13 14 15 16 17
18 19 20 21 22 23 24
25 26 27 28 01 02 03
All events   |  Future events

Job portal

Life Science Business Development Manager Europe Asia, Hybrigenics Services SAS: Business Development Europe Asia, Paris or European city, France
read more

Job portal page

Follow us on Facebook

Follow us on Twitter

Follow us on LinkedIn

Follow us on Instagram

ChemBridgeBoehringer IngelheimNovartisProf Dr W. Th. Nauta FoundationPfizerServierRocheSanofiGalChimia
Prous Institute for Biomedical ResearchUCBJanssen R&DBayerMerckAstra ZenecaIdorsiaMercachemsyncom